PL2964215T3 - Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych - Google Patents

Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych

Info

Publication number: PL2964215T3
Authority: PL; Poland
Prior art keywords: mixture; treatment; fatty acids; inflammatory pathologies; pathologies
Prior art date: 2013-03-08

Application number

PL14708015T

Other languages

English (en)

Inventor

Lodovico BURATTIN

Original Assignee

Again Life Italia Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-08

Filing date

2014-03-04

Publication date

2020-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2964215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-04 Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl

2020-03-31 Publication of PL2964215T3 publication Critical patent/PL2964215T3/pl

Links

235000014113 dietary fatty acids Nutrition 0.000 title 1
229930195729 fatty acid Natural products 0.000 title 1
239000000194 fatty acid Substances 0.000 title 1
150000004665 fatty acids Chemical class 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000007170 pathology Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fats And Perfumes (AREA)

PL14708015T 2013-03-08 2014-03-04 Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych PL2964215T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201361774796P	2013-03-08	2013-03-08
IT000354A ITMI20130354A1 (it)	2013-03-08	2013-03-08	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
PCT/EP2014/054163 WO2014135529A1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies
EP14708015.4A EP2964215B1 (en)	2013-03-08	2014-03-04	Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number	Publication Date
PL2964215T3 true PL2964215T3 (pl)	2020-03-31

Family

ID=48227394

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL17169929T PL3219316T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych
PL14708015T PL2964215T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL17169929T PL3219316T3 (pl)	2013-03-08	2014-03-04	Mieszanina kwasów tłuszczowych (grupa kwasów tłuszczowych f.a.g.) do zastosowania w leczeniu patologicznych stanów zapalnych

Country Status (18)

Country	Link
US (2)	US11020365B2 (pl)
EP (2)	EP3219316B1 (pl)
AU (2)	AU2014224710B2 (pl)
CA (1)	CA2904112C (pl)
CY (2)	CY1122248T1 (pl)
DK (2)	DK3219316T3 (pl)
EA (2)	EA036724B1 (pl)
ES (2)	ES2779851T3 (pl)
HR (2)	HRP20191963T1 (pl)
HU (2)	HUE048361T2 (pl)
IT (1)	ITMI20130354A1 (pl)
LT (2)	LT3219316T (pl)
PL (2)	PL3219316T3 (pl)
PT (2)	PT3219316T (pl)
RS (2)	RS60023B1 (pl)
SI (2)	SI2964215T1 (pl)
SM (2)	SMT201900614T1 (pl)
WO (1)	WO2014135529A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20130354A1 (it)	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP7118642B2 (ja)	2014-08-08	2022-08-16	アリリサーチソシエタアレスポンサビリタリミタータセンプリフィカタ	炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
AR102008A1 (es) *	2015-09-24	2017-01-25	Brix S R L	Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
WO2019231281A1 (ko) *	2018-05-31	2019-12-05	재단법인 아산사회복지재단	폐섬유증의 예방 또는 치료를 위한 스테아르산의 용도
EP3586641A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586643A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
KR102204097B1 (ko) *	2019-01-31	2021-01-18	동신대학교 산학협력단	지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
EP4103145A4 (en) *	2020-02-12	2024-07-03	Retrotope, Inc.	DEUTERATED POLYUNSATURATED FATTY ACIDS OR THEIR ESTERS FOR COSMETIC APPLICATIONS
EP4384157A4 (en) *	2021-08-09	2025-06-25	Kentucky Equine Research, Inc.	COMPOSITIONS AND METHODS FOR MODULATING EQUINE FATTY ACID PROFILES
CA3231729A1 (en) *	2021-11-24	2023-06-01	Jenivision Inc.	Delivery methods for treating brain and central nervous system diseases
CN119385999A (zh) *	2024-11-06	2025-02-07	中国人民解放军军事科学院军事医学研究院	壬二酸在制备防治放射性肺损伤药物中的应用
CN120000629B (zh) *	2025-01-22	2025-12-05	华南师范大学	壬二酸在制备防治脓毒症急性肺损伤药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993021912A1 (de) *	1992-04-28	1993-11-11	Fresenius Ag	Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
UY24246A1 (es) *	1995-06-06	1996-06-14	Neutrogena Corp	Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
EP1175901B1 (en) *	1999-04-15	2006-05-31	Kaneka Corporation	Peroxisome activator-responsive receptor agonists
GB9923738D0 (en)	1999-10-07	1999-12-08	Nestle Sa	Nutritional composition
DE10161729A1 (de)	2001-12-15	2003-06-18	Mira Ursic	Medizinische bzw. pharmazeutische Salbenzubereitung
EP1358872B1 (de)	2002-04-30	2008-03-12	Cognis IP Management GmbH	Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US7612111B2 (en) *	2003-03-20	2009-11-03	Imagenetix, Inc.	Esterified fatty acid composition
US20080057552A1 (en) *	2006-08-31	2008-03-06	Inmok Lee	Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en)	2006-12-20	2009-07-31	Seperex Nutritionals Ltd	An extract
JP4512881B2 (ja) *	2007-11-27	2010-07-28	築中島	薬用油脂
MX2010010214A (es) *	2008-03-20	2010-12-21	Virun Inc	Derivados de vitamina e y sus usos.
US20090264520A1 (en)	2008-04-21	2009-10-22	Asha Lipid Sciences, Inc.	Lipid-containing compositions and methods of use thereof
WO2010049954A1 (en) *	2008-10-31	2010-05-06	Lipid Pharmaceuticals Ehf.	Fatty acids for use as a medicament
ES2574136T5 (es)	2009-04-17	2019-08-30	Natac Pharma S L	Composiciones ricas en ácidos grasos omega 3 con un bajo contenido en ácido fitánico
EP2796129B1 (en) *	2009-09-07	2015-06-17	Epitech Group S.r.l.	Composition containing ultra - micronized palmitoyl - ethanolamide
CA2703532C (en)	2010-05-10	2018-05-01	Eva Turley	Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de)	2010-05-27	2011-12-01	Intendis Gmbh	Azelainsäurehaltige Formulierung mit Pigmentzusatz
PT2661266T (pt)	2011-01-07	2020-11-30	Anji Pharma Us Llc	Terapias com base em ligandos do recetor quimiossensorial
US20120252888A1 (en) *	2011-03-29	2012-10-04	Palupa Medical Ltd.	Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) *	2013-03-08	2014-09-09	Again Life Italia Srl	Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

2013
- 2013-03-08 IT IT000354A patent/ITMI20130354A1/it unknown
2014
- 2014-03-04 EA EA201791885A patent/EA036724B1/ru unknown
- 2014-03-04 PL PL17169929T patent/PL3219316T3/pl unknown
- 2014-03-04 LT LTEP17169929.1T patent/LT3219316T/lt unknown
- 2014-03-04 PT PT171699291T patent/PT3219316T/pt unknown
- 2014-03-04 SI SI201431377T patent/SI2964215T1/sl unknown
- 2014-03-04 CA CA2904112A patent/CA2904112C/en active Active
- 2014-03-04 RS RS20200252A patent/RS60023B1/sr unknown
- 2014-03-04 HU HUE17169929A patent/HUE048361T2/hu unknown
- 2014-03-04 ES ES17169929T patent/ES2779851T3/es active Active
- 2014-03-04 HU HUE14708015A patent/HUE046239T2/hu unknown
- 2014-03-04 SI SI201431512T patent/SI3219316T1/sl unknown
- 2014-03-04 WO PCT/EP2014/054163 patent/WO2014135529A1/en not_active Ceased
- 2014-03-04 DK DK17169929.1T patent/DK3219316T3/da active
- 2014-03-04 EA EA201591680A patent/EA035091B1/ru unknown
- 2014-03-04 US US14/772,768 patent/US11020365B2/en active Active
- 2014-03-04 RS RS20191396A patent/RS59523B1/sr unknown
- 2014-03-04 HR HRP20191963TT patent/HRP20191963T1/hr unknown
- 2014-03-04 EP EP17169929.1A patent/EP3219316B1/en active Active
- 2014-03-04 LT LT14708015T patent/LT2964215T/lt unknown
- 2014-03-04 EP EP14708015.4A patent/EP2964215B1/en active Active
- 2014-03-04 DK DK14708015T patent/DK2964215T3/da active
- 2014-03-04 ES ES14708015T patent/ES2753257T3/es active Active
- 2014-03-04 AU AU2014224710A patent/AU2014224710B2/en not_active Ceased
- 2014-03-04 PL PL14708015T patent/PL2964215T3/pl unknown
- 2014-03-04 PT PT147080154T patent/PT2964215T/pt unknown
- 2014-03-04 SM SM20190614T patent/SMT201900614T1/it unknown
- 2014-03-04 SM SM20200115T patent/SMT202000115T1/it unknown
2018
- 2018-03-27 AU AU2018202190A patent/AU2018202190B2/en not_active Ceased
2019
- 2019-11-05 CY CY20191101148T patent/CY1122248T1/el unknown
2020
- 2020-03-10 HR HRP20200394TT patent/HRP20200394T1/hr unknown
- 2020-03-16 CY CY20201100229T patent/CY1122783T1/el unknown
2021
- 2021-04-29 US US17/244,036 patent/US20210290578A1/en active Pending

Also Published As

Publication number	Publication date
HRP20191963T1 (hr)	2020-01-24
DK2964215T3 (da)	2019-11-11
AU2018202190A1 (en)	2018-04-26
ES2753257T3 (es)	2020-04-07
HUE046239T2 (hu)	2020-02-28
AU2014224710B2 (en)	2018-04-12
EP2964215B1 (en)	2019-08-21
PT3219316T (pt)	2020-03-27
EA201791885A1 (ru)	2018-01-31
RS60023B1 (sr)	2020-04-30
LT3219316T (lt)	2020-04-10
SMT201900614T1 (it)	2020-01-14
HRP20200394T1 (hr)	2020-06-12
HUE048361T2 (hu)	2020-08-28
PT2964215T (pt)	2019-11-12
RS59523B1 (sr)	2019-12-31
US20160015666A1 (en)	2016-01-21
CY1122248T1 (el)	2020-11-25
LT2964215T (lt)	2019-11-25
AU2014224710A1 (en)	2015-09-10
WO2014135529A1 (en)	2014-09-12
CA2904112C (en)	2021-03-23
EP2964215A1 (en)	2016-01-13
ITMI20130354A1 (it)	2014-09-09
SI2964215T1 (sl)	2019-12-31
US11020365B2 (en)	2021-06-01
EA035091B1 (ru)	2020-04-27
CA2904112A1 (en)	2014-09-12
EP3219316A1 (en)	2017-09-20
ES2779851T3 (es)	2020-08-20
DK3219316T3 (da)	2020-03-16
EA036724B1 (ru)	2020-12-11
PL3219316T3 (pl)	2020-06-01
HK1243924A1 (en)	2018-07-27
CY1122783T1 (el)	2021-05-05
EP3219316B1 (en)	2020-02-19
SMT202000115T1 (it)	2020-05-08
EA201591680A1 (ru)	2015-12-30
US20210290578A1 (en)	2021-09-23
SI3219316T1 (sl)	2020-07-31
AU2018202190B2 (en)	2019-05-02

Publication	Publication Date	Title
SMT201900614T1 (it)	2020-01-14	Miscela di acidi grassi(f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie
PL3020401T3 (pl)	2020-05-18	Pemafibrat do stosowania w leczeniu niealkoholowej stłuszczeniowej choroby wątroby
SG10201800243XA (en)	2018-02-27	SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
IL243976A0 (en)	2016-04-21	kdm1a inhibitors for disease treatment
PL2997117T3 (pl)	2019-08-30	Zastosowanie estru
IL250271A0 (en)	2017-03-30	A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
EP2941252A4 (en)	2016-07-13	USE OF FATTY ACID NIACIN CONJUGATES FOR THE TREATMENT OF DISEASES
ZA201604225B (en)	2017-08-30	Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
ZA201507724B (en)	2019-02-27	The treatment of inflammatory disorders
IL245199A (en)	2017-02-28	Processes for making unsaturated esters
SI3021873T1 (sl)	2018-12-31	Sestavek za zdravljenje vnetne sklepne bolezni
IL242711B (en)	2019-05-30	Agomelatine formulations comprising agomelatine in the form of co-crystals
PL3079684T3 (pl)	2020-06-01	Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
SG11201601297YA (en)	2016-03-30	Supported composition and the use thereof in methods for the hydroformylation of unsaturated compounds
GB201208974D0 (en)	2012-07-04	Improvements in the manufacture of fatty acids
HK1232769A1 (en)	2018-01-19	Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
GB201104653D0 (en)	2011-05-04	Improvements in the manufacture of fatty acids
GB201315079D0 (en)	2013-10-02	Novel compounds useful for the treatment of degenerative and inflammatory diseases
GB201314016D0 (en)	2013-09-18	Novel compounds useful for the treatment of degenerative and inflammatory diseases